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Abstract
Sphingolipids regulate several aspects of cell behavior and it has been demonstrated that
cells adjust their sphingolipid metabolism in response to metabolic needs. Particularly,
sphingosine-1-phosphate (S1P), a final product of sphingolipid metabolism, is a potent bio-
active lipid involved in the regulation of various cellular processes, including cell prolifera-
tion, cell migration, actin cytoskeletal reorganization and cell adhesion. In previous work in
rat renal papillae, we showed that sphingosine kinase (SK) expression and S1P levels are
developmentally regulated and control de novo sphingolipid synthesis. The aim of the pres-
ent study was to evaluate the participation of SK/S1P pathway in the triggering of cell differ-
entiation by external hypertonicity. We found that hypertonicity evoked a sharp decrease in
SK expression, thus activating the de novo sphingolipid synthesis pathway. Furthermore,
the inhibition of SK activity evoked a relaxation of cell-cell adherens junction (AJ) with accu-
mulation of the AJ complex (E-cadherin/β-catenin/α-catenin) in the Golgi complex, prevent-
ing the acquisition of the differentiated cell phenotype. This phenotype alteration was a
consequence of a sphingolipid misbalance with an increase in ceramide levels. Moreover,
we found that SNAI1 and SNAI2 were located in the cell nucleus with impairment of cell dif-
ferentiation induced by SK inhibition, a fact that is considered a biochemical marker of epi-
thelial to mesenchymal transition. So, we suggest that the expression and activity of SK1,
but not SK2, act as a control system, allowing epithelial cells to synchronize the various
branches of sphingolipid metabolism for an adequate cell differentiation program.
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1. Introduction
Sphingolipids regulate several aspects of cell behavior and it has been demonstrated that cells
adjust their sphingolipid metabolism in response to metabolic needs [1,2]. The de novo synthe-
sis of sphingolipids begins with the condensation of serine and a fatty acylCoA by serine pal-
mitoyl-CoA transferase (SPT) to form 3-ketosphinganine, followed by its reduction to
dihydrosphingosine, to be further acylated to form dihydroceramide (DHCer), which is then
desaturated to form ceramide (Cer). Cer is the central core lipid in the metabolism of sphingo-
lipids from which sphingomyelin (SM) and glycosphingolipids are synthesized. Cer is also pro-
duced by the salvage pathway, initiated by hydrolysis of SM or glycosphingolipids. Cer can be
broken down by ceramidases to form sphingosine, which is in turn phosphorylated by sphin-
gosine kinase (SK) to form sphingosine-1-phosphate (S1P) [1,3,4]. S1P is a final product of
sphingolipid metabolism and its degradation by the S1P lyase serves as a single point of degra-
dation of all sphingolipids. S1P is a potent bioactive lipid involved in the regulation of various
cellular processes, such as cell proliferation, cell migration, actin cytoskeletal reorganization
and cell adhesion [5,6]. As a signaling molecule, S1P exerts effects through both intracellular
and extracellular mechanisms [7]. In previous work, we showed that SK/S1P pathway is devel-
opmentally regulated in rat renal papillae [8]. Thus, the developmental regulation of SK
expression and activity leads sphingolipid metabolism to high levels of S1P in the neonatal
period and a decreased expression of SK in the adult. We have also shown that the SK/S1P
pathway controls the de novo synthesis of sphingolipids, exerting a negative modulation of
SPT and DHCer/Cer synthases and displaying a dynamic interplay between the de novo syn-
thesis and S1P levels [9].
Madin-Darby Canine Kidney (MDCK) is a cell line derived from dog renal collecting ducts
used as a model to study epithelial cell polarization and differentiation [10]. The physiological
condition for renal collecting duct cells is external hypertonicity, a condition under which
MDCK cells express channels, pumps and co-transporters, typical of functional differentiated
cells [11–13]. We have also previously reported that, under external hypertonicity, MDCK
cells acquire the fully differentiated morphological epithelial cell phenotype, which is driven by
changes in sphingolipid metabolism. In fact, cell differentiation is accompanied by an increase
in SM synthesis and an increase in C24:0 and C24:1 glucosylceramide (GluCer) generated
from the Cer recycling pathway [14–16]. While the increase in SM synthesis is involved in the
assembly of a mature adherens junction (AJ) [15], the development of a differentiated apical
membrane domain depends on GluCer synthesis [14].
In epithelia, AJ assembly is essential for the development and maintenance of tissue struc-
ture and mandatory for epithelial cell polarization. The most important component of epithe-
lial AJ is E-cadherin (E-cad), which, by homophilic contacts, builds a cluster on the surface of
epithelial cells to determine cell shape, maintain tissue integrity, and generate forces through-
out the tissue. E-cad maintains cytoskeletal dynamics through linkage of the cytoplasmic
domain to the actin cytoskeleton via catenins. While β-catenin (β-cat) binds directly to the dis-
tal amino acids of the E-cad cytoplasmic domain, α-catenin (α-cat) associates both with β-cat
and the actin cytoskeleton. The stoichiometry of the E-cad/β-cat/α-cat complex is 1:1:1. Previ-
ous studies have reported that β-cat binds to the cytoplasmic domain of E-cad shortly after E-
cad is synthesized at the endoplasmic reticulum (ER) and that such complex coupling assem-
bly is necessary for an efficient ER exit [17,18]. Contrary to the implication of E-cad as a key
molecule in cell differentiation, loss of E-cad expression is often used as a marker for epithelial
to mesenchymal transition (EMT) and cancer progression [19,20]. E-cad is potentially
repressed by Slug (SNAI2) and Snail (SNAI1), which are master regulatory transcription fac-
tors involved in the EMT of cancer cells [21–23].
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Considering our previous observation that S1P production is developmentally regulated,
showing the highest value in proliferating non-differentiated cells and gradually decreasing to
finally reach the lowest level in fully differentiated tissue [9], we were interested in studying
whether the production of S1P plays a role in the process of cell differentiation. We found that
cell differentiation induced by hypertonicity evokes a sharp decrease in SK expression, thus
inducing the regulation of the de novo sphingolipid synthesis pathway. Furthermore, the inhi-
bition of SK activity evokes a relaxation of cell-cell AJ with accumulation of the AJ complex
(E-cad/β-cat/α-cat) in the Golgi complex, preventing the acquisition of a differentiated
phenotype.
2. Materials and methods
2.1. Cell culture and treatment
MDCK cells (ATCC) were seeded at 0.2 x 106 cells/mL density in six-well multidishes (growth
area 9.5 cm2) and grown in DMEM/F-12 (42400010, Thermo Fisher Scientific) containing
10% fetal bovine serum (FBS), penicillin (100 μg/mL) and streptomycin (100 μg/mL) at 37˚ C
in humidified 5% CO2 atmosphere. After 24 h, the medium was replaced by DMEM/F12 con-
taining 0.5% FBS to synchronize the cell cycle, and cells were incubated for another 24 h. Pro-
liferative cells corresponded to the culture obtained at this point (Prolif). Completely confluent
cells were incubated for additional 48 h in the same conditions (Iso). For differentiated cells,
proliferative cells were switched to a hypertonic medium (300 mM NaCl) containing 1% of
FBS with or without inhibitors and further incubated for 48, 72 or 96 h. S1P-depleted FBS was
used as control in a parallel experiment. SK was inhibited by L-threo-dihydrosphingosine and
SKI II, SPT by myriocin at 100 nM and Cer synthase by Fumonisin B1 at 20 μM (all from
Sigma-Aldrich). In the experiment where exogenous S1P was added, the final concentration
was 10 μM. S1PR1 was blocked by 10 μM W146 (Sigma-Aldrich) and S1PR2 by 10 μM JTE-013
(Sigma-Aldrich). The treatments were performed for 48, 72 or 96 h, as indicated in Results.
For all the incubations, the medium containing the enzyme inhibitors or the S1P was replaced
every 24 h. At the end of each incubation, the cells were collected by trypsinization and
counted. Cell viability was determined by the Trypan Blue Exclusion method. To obtain S1P-
depleted FBS, 1 volume of FBS was extracted with n-butanol:diisopropyl ether 1:2 according to
the method of Cham and Knowles [24]. Two additional steps of solvent evaporation by nitro-
gen stream for 2 h and a dialysis against PBS in 250 volumes with three buffer exchanges at
4˚C for 3 days were performed.
2.2. Sphingolipid analysis
In order to evaluate sphingolipid synthesis, MDCK cells were incubated with 25 nCi/mL radio-
active precursor [1-14C] palmitic acid (PerkinElmer) for 4 h to evaluate newly synthetized
metabolites [25]. After trypsinization, lipids were extracted by the method of Bligh and Dyer
and mild alkaline hydrolysis was performed for sphingolipid extraction [25]. After extracted
lipid were dried by a stream of nitrogen, sphingolipid was resolved by thin layer chromatogra-
phy (TLC). SM and S1P were resolved by Silica Gel 60 TLC plates (Merck Millipore) using
1-butanol:acetic acid:water (3:1:1, v:v:v). For Cer and GluCer analysis, the TLC was developed
in two different solvents. First, the TLC was developed to two-thirds of the plate in the same
solvent system as before and then, the plate was cut at Rf = 0.8 (just above the sphingosine
standard), and the remaining piece of the plate was developed in chloroform:methanol
(50:1.5) [15,16]. Radioactive resolved sphingolipids were scanned (Storm 840, GE Healthcare).
The corresponding radioactive spots were scraped off TLC plates for additional measurement
by liquid scintillation counting.
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2.3 Sphingosine kinase activity
SK activity was assessed by measuring the conversion of [3H] sphingosine to [3H] S1P. Before
trypsinization, MDCK cells were incubated for 4 h with 0.6 μCi [3-3H] sphingosine (PN:
NET1072050UC, PerkinElmer Life Sciences). S1P extraction was optimized by using 0.1 N
HCl for phase separation during Bligh and Dyer [26]. Both [3H] sphingosine and [3H] S1P
were resolved and analyzed as described above and visualized with ninhydrin using standard-
quality sphingosine and S1P. For endogenous S1P measurement, iodine vapors were used for
visualization.
2.4. Immunoblot analysis
After washing with phosphate buffer saline (PBS), cells were scraped, resuspended in lysis
buffer (50 mM HEPES, 1% Triton X-100, 150 mM NaCl, 1 mM PMSF, 1 μg/mL aprotinin, 1
mM leupeptin, 200 μM NaVO4), and sonicated. Aliquots were incubated with 4X Laemmli
buffer at 100˚C for 5 min and resolved in a 12.5% SDS-polyacrylamide gel and blotted to poly-
vinylidene fluoride membranes. Blots were blocked with 5% nonfat milk in TBS-Tween incu-
bated overnight at 4˚C with 1:1000 goat antibody anti-SK1 (polyclonal, PC727; Oncogene) in
1% BSA in TBS-Tween. After washing, blots were incubated with donkey 1:5000 anti-goat
antibodies (polyclonal, W10825; Thermo Fisher Scientific) and bands evidenced by means of
the ECL plus analysis system (32106; Thermo Fisher Scientific). The intensity of each band
was estimated by optical densitometry by using ImageJ software.
2.5. Fluorescence microscopy
MDCK cells were grown on coverslips during cell seeding. At the end of the corresponding
treatments cells were washed with PBS and fixed with 4% (m/v) paraformaldehyde at 25˚ C for
20 min, and permeabilized with 0.1% (v/v) Triton X-100 at 25˚ C for 20 min. After washing
with PBS, cells were incubated with 3% BSA in PBS at 25˚ C for 60 min, followed by incubation
for 90 min with the primary antibodies: 1:250 mouse anti-α-catenin (polyclonal, C2081;
Sigma), 1:200 rabbit anti-β-catenin (monoclonal, C7082; Sigma), 1:50 rabbit anti-E-cadherin
(polyclonal, SC-7870, Cruz Biotechnology), 1:300 mouse anti-giantin (monoclonal, ab37266;
Abcam), 1:50 rabbit anti-SNAI1 (polyclonal, SC-281999; Santa Cruz Biotechnology) and 1:50
rabbit anti-SNAI2 (polyclonal, SC-15391; Santa Cruz Biotechnology). Primary interactions
were detected by using a 1:200 F(ab́ )2 fragment of goat anti-rabbit IgG and a 1:200 F(ab́ )2
fragment of goat anti-mouse IgG (polyclonal, 115-095-166, 115-024-166, 111-025-144, 111-
095-003; Jackson ImmunoResearch), both FITC or TRITC. Actin filaments were visualized by
1 μg/mL phalloidin-FITC (P5282, Sigma-Aldrich) and the ER with 0.20 μg/mL concanavalin
A-TRITC (C860; Thermo Fisher Scientific). The coverslips were then mounted onto micro-
scope glass slides with Vectashield Mounting Media (H-1000; Vector Laboratories) and stored
at -20˚C until analysis.
2.6. Cell transfection
MDCK cells grown on coverslips were subjected to a transient protein expression protocol.
Transfection was carried out 4 h before adding the hypertonic medium by using 0.5 μg of plas-
mid and the TransIT-X2 Dynamic Transfection System (MIR6003, Mirus Bio LLC), according
to the manufacturer’s instructions. GalT2-YFP plasmid was a gift from Dr. Daniotti [27].
For siRNA transfection, MDCK cells were grown in DMEM/F-12 containing 10% FBS
without antibiotics for 24 h. Then, cells were cultured in DMEM/F-12 containing 0.5% FBS
and transfected with 100 nM double-stranded siRNAs for SK1, SK2 or negative sequence
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using HiPerFect transfection reagent (301705, Qiagen) according to the manufacturer’s
instructions. After 24 h, transfection reagents were washed out and the medium was replaced
by DMEM/F-12 containing 1% FBS and incubated with 300 mM NaCl for 48 h. The sequences
of siRNAs for SK1 were 5’ GGGCAAGGCUCUGCAGCUCdTdT 3’ (sense) and 50 GAGCUG
CAGAGCCUUGCCCdTdT 30 (antisense); for SK2 were 5’ GGGCAAGGCUCUGCAGCUCdTdT
3’ (sense) and 5’ UUCAGCUCCUUAUCGGCGCdTdT 3’ (antisense); and the sequences for
the negative siRNA were 50 CAGUCGCGUUUGCGACUGG 30 (sense) and 50 CCAGUCGCAA
ACGCGACUG 30 (antisense). To identify the siRNA transfected cells during the fluorescent
microscopy analysis, cells were co-transfected with Negative Control siRNA-Alexa546 (Qia-
gen) according to the manufacturer’s protocol.
2.7. Imaging and data processing
Cells were examined by confocal immunofluorescence using an Olympus FV300 confocal
microscope (model BX61) equipped with Ar and He-Ne lasers, and 60× oil immersion and
numerical aperture 1.40. Images were taken with the acquisition software FluoView version
3.3. A minimum of 10 fields containing several cells were collected from each sample. Man-
ders’ overlap coefficient was obtained using Coste’s auto-thresholding in ImageJ software. The
line profile was performed in the corresponding area of each cell and data for the graph were
obtained using ImageJ software. Nyquist criterion was applied to optimize the lateral (XY) and
axial resolution (Z) [28]. Therefore, the microscope was set for a lateral resolution of 46 nm
and an axial resolution of 150 nm. Image stacks were processed by ImageJ software for z-plane
reconstruction or by UCSF Chimera software for 3D reconstruction. The nucleus/cytoplasm
ratio was obtained by creating regions of interest on the Hoechst-positive pixels using the Ima-
geJ software.
2.8 Statistics
At least three independent experiments were performed and results were analyzed using
Graph Pad Prism Version 6.0 software (Graph Pad Software Inc). Data were shown as the
mean ± standard deviation (SD). Statistical comparisons were made by analysis of variance
(ANOVA) with Bonferroni post hoc analysis. A ‘p’ value under 0.05 was considered statisti-
cally significant.
3. Results
3.1. Hypertonicity induces changes in SK expression and S1P levels
Considering that, as we have previously demonstrated, SK is developmentally regulated in rat
renal papillae [8] and that external hypertonicity evokes MDCK differentiation [14,15], we
first evaluated SK expression in four different culture conditions: cells cultured at 30% conflu-
ence (Prolif), cells at 100% confluence under isotonicity (Iso), and 100% confluent cells sub-
jected to hypertonicity for 48 h (H48) or 96 h (H96), which reflect proliferating, polarized and
differentiated cells by hypertonic media for 48 or 96 h, respectively (Fig 1A). As shown in the
graph and considering SK expression under proliferative conditions as 100%, we observed a
33% decrease in SK expression in polarized cells and a 65% decrease in differentiated cells (48
h (H48) or 96 h (H96)). To determine whether differences in protein levels caused differences
in SK activity, we further studied S1P production. For this purpose, proliferative (Prolif),
polarized (Iso) and differentiated cells (H48), were incubated in the presence of [
3H] sphingo-
sine as substrate and radiolabeling was carried out for 4 h. Then, supernatants were collected
and cells were trypsinized and subjected to lipid extraction, followed by methanolysis of
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phospholipids and triglycerides. Sphingolipids were resolved by TLC as described in Materials
and Methods and [3H] S1P spots were scraped and counted by Liquid Scintillation Counter.
As shown in Fig 1B, the highest production of [3H] S1P was obtained in proliferative cells, a
46% decrease was observed in polarized cells and as little as 37% of the control value was
Fig 1. Decrease in SK expression and activity during MDCK cell differentiation. (A) SK protein levels in
proliferative (Prolif), polarized (Iso) and differentiated for 48 (H48) or 96 h (H96) MDCK cells. β-actin was used as
endogenous control. (B) SK activity was measured using [3-3H] sphingosine as substrate. Prolif, Iso or H48 MDCK cells
were incubated with 0.6 μCi [3-3H] sphingosine for 4 h. Radioactive spots corresponding to [3H] S1P on the TLC were
scraped and quantified as described under Materials and Methods. (C) S1P from sphingolipid extract derived from
Prolif, Iso and H48 cells was resolved by TLC and visualized by iodine staining. (D) Cell number and viability were
obtained after 48 h in continued SK inhibition conditions with t-DHS or SKI II in Prolif, Iso, H48 and H96. (E) During
MDCK hypertonicity-induced cell differentiation, SK activity was determined by incubation with [3H] sphingosine in
the presence or absence of SK inhibitors (t-DHS, SKI II). Data are given as mean ± SD with n = 3, �p< 0.05.
https://doi.org/10.1371/journal.pone.0213917.g001
Sphingosine kinase and epithelial cell homeostasis
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obtained in differentiated cells. The same pattern was found when endogenous levels of S1P
were analyzed (Fig 1C). Proliferating cells showed the highest levels of S1P, followed by polar-
ized cells, whereas the differentiated cells showed the lowest levels. Summarizing, the differen-
tiated cells presented the lowest expression of SK and S1P synthesis, while proliferating cells
showed the highest value of SK expression and S1P production, both consistent with the
endogenous amount of S1P found. These results suggest that SK and S1P levels decreased dur-
ing MDCK cell differentiation.
Previous studies of our laboratory demonstrated that the survival of proliferating MDCK
cells is extremely sensitive to S1P synthesis [9]. Thus, we further evaluated S1P dependence of
MDCK cell survival by using two different SK inhibitors: t-DHS, a competitive inhibitor of SK,
and SKI II, which causes SK degradation [29,30]. Cell viability was analyzed after inhibition of
SK for 48 h in proliferating cells, polarized cells, and cells subjected to hypertonicity for 48 or
96 h. The incubation with SK inhibitors was performed in the last 48 h of culture. As during
the incubation with hypertonicity for 48 h the cells are in progress to differentiation, the new
experimental condition with cells that were subjected to hypertonicity for 48 h and incubated
for extra 48 h under hypertonicity in the presence of SK inhibitors (H96) was included to evalu-
ate the effect of SK inhibitors in already differentiated cells. The sensitivity of the cells to t-
DHS and SKI II decreased as the degree of cell differentiation increased, with proliferating
cells being the most sensitive and differentiated cells (H96) remaining refractory to SK inhibi-
tion (Fig 1D). These results suggest that S1P lost its function of maintaining cell viability as cell
differentiation progressed.
Since we were interested in determining the role of SK/S1P pathway in the progress of dif-
ferentiation, we determined S1P synthesis in cells subjected to hypertonicity (short term incu-
bation) at concentrations of inhibitors that did not affect their survival. The inhibitor
concentrations tested were 5 μM for t-DHS and 2 μM for SKI II. [3H] sphingosine was incor-
porated for 4 h after 30 min of hypertonicity with or without inhibitors. Interestingly, MDCK
cells in progress to differentiation resisted 51% and 39% inhibition of S1P synthesis with t-
DHS and SKI II, respectively (Fig 1E). These results showed that SK inhibitors already
decreased S1P synthesis without affecting cell survival.
3.2 Inhibition of S1P synthesis disrupts epithelial cell organization
After demonstrating that S1P synthesis and SK expression depend on cell physiological condi-
tions, cultured cells subjected to hypertonicity for 48 h were used to explore the influence of
S1P synthesis during epithelial cell differentiation and tissue organization. Cell morphology
and tissue organization were evaluated by determining F-actin distribution using phalloidin-
FITC as fluorochrome and performing confocal microscopy observing three different confocal
planes: the most basal plane, where cells are attached to the extracellular matrix, a middle
plane, and the most apical plane, which corresponds to the luminal side of the cell. In control
cells subjected to hypertonicity for 48 h (H48), F-actin appeared delimiting the cells in the
three confocal planes analyzed (Fig 2A). In the most basal plane, F-actin was also organized as
short stress fibers, thus demonstrating a correct cell-extracellular matrix attachment, while, in
the middle plane, F-actin appeared exclusively forming the cellular cortex. In the apical plane,
besides drawing the limits of the cells, F-actin showed a punctate appearance, demonstrating
the presence of bundles of actin filaments organized into the microvilli typical of the mature
apical membrane domain [31]. Next, we examined the effect of blocking S1P production at the
time of triggering cell differentiation by hypertonicity by using both inhibitors at concentra-
tions that did not affect the cell number or survival, as described above. Both inhibitors
induced alterations in F-actin organization (Fig 2B and 2C). Thus, the cortex of F-actin
Sphingosine kinase and epithelial cell homeostasis
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Fig 2. SK inhibition induces actin cytoskeleton reorganization. During MDCK cell differentiation by hypertonicity
(Control: Hyper) (A), monolayers were subjected to SK inhibition by t-DHS (B) or SKI II (C). Fixed-cell monolayers
were labeled for F-actin with phalloidin-FITC and images were taken by confocal microscopy in 4-μm sections,
determining basal, middle (mid) and apical cell planes. High magnification insets of the open rectangles are shown
below each image.
https://doi.org/10.1371/journal.pone.0213917.g002
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drawing the cell limits was impaired in the three confocal planes analyzed. Besides the alter-
ation in the cortical F-actin organization, the most basal plane exhibited the formation of lon-
ger and parallel fibers of actin, distinctive of migrating and not stabilized epithelial cells. In the
middle plane, intracellular puncta of actin were also present, which were more evident in the
apical plane. Besides the alteration in F-actin evoked by inhibition of S1P production both
with t-DHS and SKI II, the cells subjected to hypertonicity did not acquire the classic hexago-
nal shape proper of differentiated epithelial cells. Instead, SK inhibition evoked a fibroblast-
like phenotype when treated with t-DHS, as observed in the magnified image of the middle
plane. In both cases, the cell-cell contact was profoundly altered and, when treated with SKI II,
the cells appeared rounded.
3.3. S1P biosynthesis is required for mature AJ complex formation
It is accepted that, to organize as epithelial tissue, epithelial cells have to adhere to each other
through the formation of stable AJ structures. AJs are visualized by analyzing the distribution
of AJ proteins. To assess whether S1P is involved in the acquisition of mature AJs, we first ana-
lyzed E-cad and β-cat colocalization and then β-cat and α-cat localization by confocal micros-
copy. In control differentiated cells (H48), the immunolabeling for both E-cad and β-cat
showed that they appeared delineating the cell periphery, showing a high degree of colocaliza-
tion as seen in the merge image, thus reflecting the presence of mature AJs (Fig 3A).
3.4. SK inhibition causes accumulation of the AJ protein complex in the
trans-Golgi network (TGN)
After observing that SK inhibition evoked an intracellular accumulation of the AJ complex, we
further studied its subcellular localization by confocal microscopy. Colocalization was ana-
lyzed by the Manders’ Overlap Coefficient with Costes auto-thresholding (MOC), which indi-
cates co-occurring positive pixels of a pair of two fluorophores as a fraction of the total
number of positive pixels of each fluorophore (m1 and m2). The m1 and m2 values range from
0 to 1.0, where an m1 value of 0 means that there are no fluorochrome 1 pixels overlapping
with positive pixels for fluorochrome 2, and a value of 1.0 indicates complete overlapping of
fluorochrome 1 with positive pixels for fluorochrome 2 [32]. For this set of images, we assigned
the AJ proteins pixels in the probed organelle marker pixels as an m1 value. Considering that it
is accepted that β-cat can translocate to the nucleus and thus operate as a transcription factor,
we first investigated the localization of β-cat in the nucleus. To this end, control cells (H48) and
t-DHS- or SKI II-treated cells were stained by immunofluorescence for β-cat in the presence
of a nuclear marker (Hoechst). Both markers had different distribution and β-cat accumulated
in the proximity but not in the nucleus (Fig 4A). The quantitative analysis showed that the
fractions of β-cat in nuclear positive pixels were m1 = 0.01 for control cells (H48), m1 = 0.09 for
t-DHS-treated cells and m1 = 0.07 for SKI II-treated cells, thus demonstrating no nuclear accu-
mulation of β-cat.
Then, we tested the colocalization of β-cat with markers for the ER, cis/medial Golgi or
TGN. ER visualization was performed by the lectin Concavalin A-TRITC. Both control cells
(H48) and treated cells (H48+t-DHS48 or H48+SKI II48) showed a low level of overlapping
between intracellularly accumulated β-cat and concanavalin A-positive pixels (m1 = 0.21 for
H48, m1 = 0.29 for t-DHS-treated cells and m1 = 0.28 for SKI II-treated cells) (Fig 4A). Thereaf-
ter, the cis/medial Golgi was immunostained for giantin and the quantitative overlapping was
analyzed (Fig 4A). For both inhibitors, images showed an intense labeling for β-cat in the prox-
imity of the label for giantin, but no colocalization. Thus, the values observed by the colocaliza-
tion analysis were m1 = 0.01 for control cells (H48), m1 = 0.05 for t-DHS-treated cells and m1 =
Sphingosine kinase and epithelial cell homeostasis
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0.014 for SKI II-treated cells. Finally, the TGN was visualized by detection of GalT2-YFP
(UDP-Gal:GA2/GM2/GD2 β-1,3-galactosyltransferase) expression (Fig 4B). Both the confocal
images and the MOC showed high colocalization for β-cat and the TGN marker in t-DHS-
and SKI II-treated cells, being m1 = 0.97 and m1 = 0.96, respectively.
We further performed a line profile analysis where a set of intensity values taken from regu-
larly spaced points along a line segment are shown in a graph. The line profile analysis is useful
to show colocalization as overlapping peaks. In Fig 4B–4D, line profiles are displayed in verti-
cal format on the left of each set of images corresponding to the solid white line in the micros-
copy images. The line profile of control cells (H48) shows β-cat (to the right side of the graph)
only as two peaks located at the AJ area. Instead, pixels positive for GalT2 (to the left side of
the graph) are located between the β-cat-positive peaks traced over the image shown. This
demonstrates that both signals are differently distributed in the cells. The images obtained for
SK inhibition (H48+t-DHS48 or H48+SKI II48) show β-cat peaks in the zone of AJs but also a
central accumulation with the maximum of this peak occurring at the same points where
peaks for GalT2 are located, thus reflecting perfect β-cat-GalT2 co-distribution. Due to the
three-dimensional architecture of the Golgi complex, we decided to incorporate additional
approaches by reconstructing a lateral view (XZ planes, indicated as a white dotted line) and a
3D view. To this end, Z-series of confocal images were collected every 0.15 μm calculated
based on Nyquist criterion [28] from monolayers subjected to hypertonicity in the presence or
absence of SK inhibitors. As seen in the images, the ZX and 3D plane reconstruction show
that, in control cells (H48), β-cat is present only as a line delimiting the cells while GalT2 is
intracellular, but that, in treated cells, β-cat appears as an underdrawing line and intracellularly
colocalizing with GalT2.
Thereafter, we also analyzed the α-cat and E-cad accumulation induced by SK inhibition in
the TGN. To this end, cells were immunostained for α-cat (Fig 4C) or E-cad (Fig 4D) in com-
bination of GalT2-YFP expression. The images, line profile, reconstructions and MOC con-
firmed the co-distribution of both α-cat and E-cad with the TGN marker, showing a perfect
coincidence between the intracellular localization of AJ protein and GalT2-YFP.
Taken together, these results and those in Fig 3 suggest that E-cad, β-cat and α-cat accumu-
late as a complex in the TGN when SK is inhibited in cells in progress to differentiation.
Fig 3. SK inhibition during cell differentiation causes AJ alterations. During MDCK cell differentiation by
hypertonicity, monolayers were submitted to SK inhibition (t-DHS or SKI II). Middle confocal planes of monolayers
labeled for (A) E-cad (green) and β-cat (red) or (B) α-cat (green) and β-cat (red) and the corresponding merge are
shown. High magnification insets of the open rectangles in merge images are shown below each panel. (C) E-cad
protein level was determined by Western Blot in differentiated cells (H48), or cells treated with t-DHS or SKI (H48+t-
DHS48 or H48+SKI II48). White arrows indicate zones where cell-cell junction appears separated. White arrowheads
indicate intracellular accumulation of AJ complex proteins. The pre-treatment with t-DHS or SKI II caused a
deterioration of AJs, evidenced by the appearance of zones where cell-cell separation (arrow) and loss of E-cad and β-
cat colocalization accompanied by dissipation from the cell limits were evident, especially in SKI II-treated cells. It is
interesting to note the presence of intracellular accumulation of colocalized E-cad and β-cat when cells were treated
with the SK inhibitors (arrowhead). Fig 3B shows the localization of α-cat in relationship with β-cat. As before, in
differentiated MDCK cells, both proteins colocalized in the periphery of the cells, but the inhibition of SK by t-DHS or
SKI II impaired the cell-cell contact denoted by zones where cells lost their contacts and some cells appeared
completely separated (arrow), which is more evident in the magnified images. Again, α-cat appeared intracellularly
accumulated, colocalizing with β-cat (arrowhead). Taken together, these results demonstrate that the E-cad, β-cat and
α-cat complex delocalized from the cell-cell contact and accumulated intracellularly when SK activity was blocked,
with the consequent impairment of cell-cell adhesion. Interestingly, although there was a change in the distribution of
E-cad, the immunoblot showed no changes between control cells (H48) and cells treated with t-DHS or SKI II (H48+t-
DHS48 or H48+SKI II48) (Fig 3C).
https://doi.org/10.1371/journal.pone.0213917.g003
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Fig 4. SK inhibition causes accumulation of the AJ protein complex in the TGN. Optical confocal sections perpendicular to the apico-basal axis of the
monolayer showing β-cat, nucleus, endoplasmic reticulum and Golgi markers. Dual-color immunofluorescence colocalization was performed on MDCK cells
grown on glass coverslips and treated with t-DHS or SKI II. (A) Cells were stained with anti-β-cat (green), and Hoechst for the nucleus (blue), concanavalin A
for the endoplasmic reticulum (red) or anti-giantin for the cis/medial-Golgi (red). (B, C, D) MDCK cells transfected with GalT2-YFP (TGN marker) were
treated with t-DHS or SKI II for 48 h, fixed and labeled in red for β-cat (B), α-cat (C) or E-cad (D). To the right of each panel, a XZ plane (dotted line in XY
plane images) and 3D reconstruction are shown. To the left of each panel, line profiles are displayed in vertical format (solid line in XY plane images). (A-D)
Manders’ coefficients (m1) are shown in the right inferior angle of each XY image.
https://doi.org/10.1371/journal.pone.0213917.g004
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3.5. The morphological changes evoked by the SK inhibitors are due to an
increase in sphingolipid synthesis
We have previously demonstrated that endogenously generated S1P negatively modulates SPT
and DHCer sintase (DHCerS) in proliferating cells, thus controlling the de novo synthesis of
sphingolipids [9]. To evaluate the possible implication of sphingolipid metabolism in the alter-
ation of cell-cell contact evoked by SK inhibition, we tested the combined effect of Myr or
Fumo, inhibitors of SPT and DHCerS/CerS, respectively, and the SK inhibitors, in the acquisi-
tion of the differentiated phenotype of MDCK cells. To this end, phalloidin-FITC was used to
visualize the actin cytoskeleton and immunofluorescence for β-cat was used to detect AJs.
Treatment with Myr or Fumo over SK inhibition prevented the effect of SK inhibition and
cells preserved the typical epithelial cell morphology, reflected by the preservation of the F-
actin cortex (Fig 5A). Moreover, β-cat remained delimiting the cell periphery and only slightly
stained for the intracellular accumulation. Since S1P is an intracellular mediator but can also
act extracellularly, we further added exogenous S1P over SK inhibition and observed the distri-
bution of F-actin and β-cat. The addition of S1P was not able to rescue the cell phenotype even
after 48 h of extracellular hypertonicity in the presence of exogenous S1P (Fig 5A). Besides the
alteration in cell morphology, dissipation of β-cat from the cell limits with its intracellular
accumulation was also observed. Since FBS contains S1P, we used S1P-depleted FBS at the
moment of inducing cell differentiation by external hypertonicity to rule out S1P influence in
the cultured cells. Results showed non-significant differences in β-cat or F-actin distribution
between cells cultured in S1P-depleted and non-depleted medium (S1 Fig).
These results suggest that sphingolipid metabolism is involved in the deleterious effect of
SK inhibition and that endogenous synthesis of S1P is required for the acquisition of the epi-
thelial phenotype in MDCK cells subjected to external hypertonicity.
The above results suggest that endogenous synthesis of S1P is required for the acquisition
of the typical epithelial phenotype of MDCK cells. Thereafter, we were interested in determin-
ing whether endogenous S1P is also necessary for the maintenance of the differentiated pheno-
type. To this end, we incubated cells for 48 h under hypertonicity to reach a differentiated state
and then inhibited SK activity for additional 24 h. Fluorescence microscopy of β-cat and F-
actin (Fig 5B) showed that SK inhibition did not cause changes in cell morphology, reflected
by F-actin distribution. β-cat remained delimiting the cell periphery without intracellular
accumulation. These results demonstrate that MDCK cells in progress to differentiation are
sensitive to SK inhibition while endogenous S1P does not play a role in the maintenance of the
differentiated state.
3.6. SNAI1 and SNAI2 are involved in the impairment of cell
differentiation by SK inhibition
The previous result showed that, when MDCK cells were subjected to hypertonicity in the
presence of SK inhibitors, instead of acquiring an epithelial phenotype, they adopted a fibro-
blast-like morphology accompanied by deterioration of AJs. Since it is accepted that both phe-
nomena can be related to an EMT, we further evaluated the expression and localization of the
transcription factors SNAI1 (Snail) and SNAI2 (Slug), whose nuclear localization is considered
a biochemical marker of EMT [21,33–35]. To this end, H48 and t-DHS- and SKI II-treated
cells were immunolabeled for SNAI1 and SNAI2 detection. Hoechst labeling was used to digi-
tally determine the nuclei outlines (Fig 6A). Control cells (H48) showed neither SNAI1 nor
SNAI2 nuclear location. In contrast, SK inhibition by both inhibitors induced nuclear accu-
mulation of SNAI1 and SNAI2. To evaluate the involvement of sphingolipid metabolism in
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the nuclear translocation of SNAI1/2, over the inhibition of SK, we also inhibited SPT with
Myr.
The immunofluorescence images show that the inhibition of sphingolipid metabolism pre-
vented the nuclear translocation of SNAI1/2, thus reflecting involvement of sphingolipid syn-
thesis in the process. The quantitative analysis of the immunofluorescence showed that the
nucleus/cytoplasm ratio for SNAI1 was 0.67 in control cells (H48) while those for t-DHS and
SKI II were 0.98 and 0.92, respectively. The quantification of the ratio for SNAI2 showed the
same pattern, resulting in 0.70 for control (H48), 1.05 for t-DHS and 1.12 for SKI II. Taken
together, these results demonstrate the involvement of sphingolipid metabolism in the nuclear
Fig 5. Blocking de novo sphingolipid synthesis protects from the impact of SK inhibition. The acquisition of the
differentiated phenotype was visualized. (A) SK inhibition (H48+t-DHS48 or H48+SKI II48) was combined with Myr,
Fumo (H48+t-DHS/Myr48 or H48+SKI II/Fumo48) or exogenous S1P(H48+t-DHS/S1P48 or H48+SKI II/S1P48). (B)
After 48 h of hypertonicity, cells were treated with t-DHS or SKI II for 24 additional hours in hypertonic medium (H72,
H72+t-DHS24, H72+SKI II24).
https://doi.org/10.1371/journal.pone.0213917.g005
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translocation of SNAI1 and 2 induced by SK inhibition. The inhibition of sphingolipid metab-
olism in SK-inhibited cells by Myr restored the nucleus/cytoplasm ratio to control values (Fig
6B and 6C).
3.7. Sphingolipid metabolism is increased in cells treated with SK
inhibitors
The above results showed that SK inhibition causes deleterious effects in cells in progress to
differentiation but not in already differentiated cells. On the other hand, we also showed that
such effect was prevented when cells were treated with inhibitors of sphingolipid biosynthesis.
To obtain a biochemical explanation of this phenomenon, we next studied sphingolipid syn-
thesis in cells in progress to differentiation and differentiated cells in the presence or absence
of the SK inhibitors. To this end, we used [14C] palmitic acid as a radioactive precursor, whose
incorporation can occur either by de novo synthesis or by the salvage pathway. By using the
Fig 6. Endogenous SNAI1 and SNAI2 are distributed in the nucleus of SK-inhibited cells. (A) MDCK cells under hypertonicity (H48) in the presence
of t-DHS, SKI II and t-DHS or SKI II in combination with Myr were labeled for SNAI1 (red) or SNAI2 (green) and the nucleus by Hoechst. Nuclei are
shown as outlines of the Hoechst-positive pixels. Quantification of SNAI1 (B) or SNAI2. (C) Fluorescence intensity quantification is shown as the
nucleus/cytoplasm ratio. Data are given as mean ± SD with n = 3, �p< 0.05.
https://doi.org/10.1371/journal.pone.0213917.g006
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one-dimension two-solvent system TLC, we can properly separate Cer from the final products
SM, GluCer and LacCer. An autoradiography of a representative TLC plate is shown in Fig
7A. The quantitative analysis shows that cells in progress to differentiation, in response to
treatment with SK inhibitors increased the incorporation of [14C] palmitic acid associated with
total sphingolipids (Fig 7A). The analysis of the individual sphingolipids, whose identity was
determined by mass spectrometry [16], showed that the treatment of cells with t-DHS evoked
an increase in the radioactivity associated with Cer (4.9-fold). A small but significant increase
was observed in both GluCer (1.3-fold) and SM (2.3-fold). Although lower, the same pattern
was obtained by using SKI II. To evaluate whether the increase in sphingolipid synthesis
involved de novo synthesis, Myr, a SPT inhibitor, was added simultaneously with the SK inhib-
itors. The treatment with Myr over SK inhibitors evoked a decrease of radioactivity associated
to Cer, GluCer and SM. However, the level of radioactivity associated with Cer and SM was
not lower than the control cells (H48), suggesting that Cer could be partially resynthesized by
the salvage pathway. In turn, 70% of inhibition was obtained in GluCer in cells treated with t-
DHS + Myr, reflecting that most of the GluCer is formed by de novo synthesis. In the case of
SM, the inhibition of SPT blocked only the increase induced by SK inhibition. Alternatively,
Fumo, a CerS/DHCerS inhibitor, was added to block the ceramide accumulation. Cells treated
with t-DHS + Fumo showed a more profound inhibition of Cer synthesis, while the inhibition
of GluCer and SM was similar to that induced by Myr.
The metabolic results suggest the coexistence of the de novo and salvage pathways of sphin-
golipid in MDCK cells in progress to differentiation, and that the increase induced by the SK
inhibitors is mostly due to stimulation of SPT at least for Cer and SM, the most affected sphin-
golipid metabolites.
Considering that many cell types can release S1P and activate signaling pathways through
its specific receptors (S1PR), SK inhibition was combined to exogenous S1P addition to rule
out this possibility. As seen in Fig 7B, the exogenously added S1P was not able to reverse the
increase in sphingolipid synthesis evoked by SK inhibitors, which shows that the regulation of
sphingolipid synthesis is exerted by the intracellular and not the extracellular level of S1P.
Additionally, the incubation with only S1P did not modify the sphingolipid de novo synthesis
(Fig 7B). Moreover, the incubation with S1PR1 or S1PR2 antagonist (W146 or JTE-013,
respectively) did not modify the metabolism either (S2 Fig).
Considering that FBS contains S1P and that this could affect sphingolipid metabolism, we
studied the sphingolipid de novo synthesis in cultured cells grown in medium containing S1P-
depleted FBS. As seen in S2 Fig, no differences in the incorporation of [14C] palmitic acid into
Cer, GluCer or SM were observed between S1P-depleted and non-depleted FBS (H48 non-
depleted FBS and H48 S1P-depleted FBS). Similarly, the increase of [
14C] palmitic acid incor-
poration into Cer, GluCer and SM evoked by SK inhibition was the same in S1P-depleted FBS
and non-depleted FBS (H48+t-DHS48/SKI II48 non-depleted FBS and H48+t-DHS48/SKI II48
S1P-depleted FBS). Moreover, exogenous S1P addition did not reverse the effects of SK inhibi-
tors on the SLP metabolism. These results showed that the intracellular level of S1P, but not
the extracellular one, modulates sphingolipid metabolism.
We further studied the metabolism in already differentiated cells. The pattern of distribu-
tion of [14C] palmitic acid in the various sphingolipid metabolites was similar to that of cells in
progress to differentiation (Fig 7C). However, when cells were treated with t-DHS, the change
in Cer was 1.7-fold, in GluCer 1.8-fold and in SM 4.7-fold. The same pattern, although attenu-
ated, was obtained by using SKI II as a SK inhibitor. However, it is evident that while the
change in radioactivity associated with Cer induced by t-DHS was only 1.7- vs the 4.9-fold of
the Cer in cells in progress to differentiation, the opposite occurred with SM (2.3-fold vs
4.7-fold, respectively).
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Fig 7. SK inhibition induces an increase in de novo sphingolipid synthesis. MDCK cells were labeled with [14C] palmitic acid for 4 hours before
trypsinization. Sphingolipids were developed in two solvent systems: first in butanol:acetic acid:water (60:20:20, v/v/v; solvent 1), and the top portion
of the TLC was run in solvent 2 (chloroform:methanol, 50:1.5, v/v) and detected by autoradiograph. The radioactivity associated with the cells and
culture medium was quantified using liquid scintillation for all spots. (A) Total [14C] palmitic acid incorporation in H48 and t-DHS- and SKI II-treated
cells (above), representative TLC plate (below). (B) Incorporation of [14C] palmitic acid to Cer, GluCer and SM in cells subjected to hypertonicity
(H48) in the presence of t-DHS or SKI II and combination with Myr, Fumo and S1P. (C) [
14C] palmitic acid incorporation to Cer, GluCer and SM in
cells that were differentiated for 48 hours in the presence of hypertonicity and then treated with t-DHS or SKI II for 24 additional hours under
hypertonicity (H72, H72+t-DHS24, H72+SKI II24). (D) Total and (E) relative [
14C] palmitic incorporation to Cer, GluCer and SM are shown for the
different conditions. Data are given as mean ± SD with n = 3, �p< 0.05.
https://doi.org/10.1371/journal.pone.0213917.g007
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For a better comparison between the two experimental conditions, Fig 7D shows the total
[14C] palmitic acid incorporation in the various sphingolipids in cells in progress to differenti-
ation (H48 and SK inhibitors) and in already differentiated cells (H72 and SK inhibitors).
Besides, Fig 7E shows the relative incorporation of [14C] palmitic acid to Cer, GluCer and SM
in pie charts. Whereas cells with SK inhibited during the cell differentiation process mainly
accumulated Cer (with 71% for t-DHS and 47% for SKI II) instead of SM (15% for t-DHS and
21% for SKI II), cells which had differentiated before SK was inhibited showed greater accu-
mulation of SM (37% for t-DHS and 31% for SKI II) and a reduced accumulation of Cer (36%
for t-DHS and 38% for SKI II).
These results showed that sphingolipid de novo synthesis in MDCK cells is modulated by
intracellular S1P, but the response is different according to the degree of cell differentiation.
While cells in progress to differentiation show an increase in sphingolipid synthesis reflected
mainly in Cer accumulation, already differentiated cells branch the sphingolipid metabolism
to SM and GluCer, thus evoking less accumulation of Cer. These results are consistent with
our previous reports where we showed an overexpression of GluCer synthase and SM synthase
in differentiated cells [14,15].
3.8. SK1 participates in MDCK cell differentiation
Different siRNA for SK1 or SK2 were used to assess the specificity of SK inhibitors and to dis-
sect which SK isoforms are involved in the process.
The analysis of individual sphingolipids labeled with [14C] palmitic acid showed that the
knockdown of SK1, but not SK2, evoked an increase in the radioactivity associated with Cer
(1.6-fold) and SM (1.6-fold) compared with the negative siRNA control, but no significant
increase in GluCer (Fig 8B). Although less pronounced, the same pattern was obtained in
siRNA experiments and SK inhibitor assays, which confirms that the effects on sphingolipid
metabolism observed in the pharmacological experiment were due to specific SK inhibition.
The slighter increase in radioactivity associated with the different sphingolipids was due to the
efficiency of transfection in our model (~30%). Interestingly, only SK1 knockdown was able to
modulate total sphingolipid metabolism, but not SK2, which suggests that SK1 is the isoform
involved in metabolism regulation.
After demonstrating that SK1 but not SK2 was able to control sphingolipid synthesis,
cell morphology and tissue organization were evaluated by determining F-actin distribu-
tion using phalloidin-FITC as fluorochrome and performing fluorescence microscopy. In
cells treated with negative siRNA (control), F-actin appeared delimiting the cells in trans-
fected (red dotted cells) and non-transfected cells (Fig 8C F-actin). Next, we examined the
effect of SK1 and SK2 knockdown on F-actin distribution. SK1 knockdown (red dotted
cells) induced alterations in F-actin organization which impaired the cortex of F-actin
drawing the cell limits (white arrow). Interestingly, SK2 knockdown did not alter F-actin
distribution.
In order to confirm the importance of each SK isoform in AJ maturation, E-cadh and β-cat
distribution was evaluated. As expected, in cells transfected with negative siRNA control (Fig
8B-neg, red dotted cells) both E-cad and β-cat showed appeared to delineate the cell periphery,
thus reflecting the presence of mature AJs. In cells were SK1 was silenced (Fig 8B-SK1, red dot-
ted cells), we observed the presence of intracellular accumulation of E-cad and β-cat (white
arrowhead) as compared to non-transfected neighbouring cells, which suggests that SK1
knockdown altered AJ protein distribution. On the other hand, SK2 knowndown was unable
to induce AJ protein intracellular accumulation, suggesting that SK2 is not involved in AJ
maturation.
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Taken together, knockdown experiments (in agreement with pharmacological inhibitor
experiment) showed that alterations in sphingolipid metabolism affected MDCK cell differen-
tiated morphology and impaired AJ complex distribution. Moreover, SK1, the isoform
Fig 8. SK1 participates in MDCK cell differentiation. MDCK cells were transfected with 100 nM double-stranded
siRNAs for SK1, SK2 or negative sequence. (A) SK1- or SK2-specific siRNA knockdown were checked by RT-PCR
analysis (ACTB serves as internal control). (B) Cells were labeled with [14C] palmitic acid for 4 hours before
trypsinization. Sphingolipids were developed by TLC and [14C] palmitic acid incorporation to Cer, GluCer and SM were
quantified using liquid scintillation. (C) To identify transfected cells, monolayers were cotransfected with an
Alexa546-labeled non-targeting siRNA whose signal is shown as red spots in the transfected cells. After treatment, fixed-
cell monolayers were labeled for F-actin with phalloidin-FITC, E-cad and β-cat. Data are given as mean ± SD with n = 3,
�p< 0.05.
https://doi.org/10.1371/journal.pone.0213917.g008
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involved in sphingolipid metabolism modulation, but not SK2, was associated with differenti-
ated cell morphology and AJ maturation, which reinforces the finding that de novo synthesis
regulation by SK1/S1P is necessary for epithelial cell differentiation.
4. Discussion
Our biggest goal has been to define the role of sphingolipid metabolism in cellular fate. We
have previously shown that, by modulating the expression and activity of sphingolipid meta-
bolic enzymes, MDCK cells can direct the formation of the final metabolites that define cellu-
lar fate. In fact, we have reported that SK is highly expressed in proliferative state, thus
maintaining cell proliferation and survival, while in differentiated cells, increased expression
and activity of SM synthase and GluCer synthase ensure the establishment and preservation of
cell-cell adhesion and mature apical membrane domain, typical of differentiated renal collect-
ing duct cells [14–16].
The focus of the present study was to determine whether sphingolipid metabolism influ-
ences the process of differentiation and tissue organization of renal collecting duct cells. The
results revealed that the SK1/S1P pathway, by modulating the de novo pathway of sphingolipid
synthesis, is critical for MDCK differentiation and tissue organization but does not play a role
when cells are already differentiated. The involvement of S1P in regulating the de novo biosyn-
thesis of Cer has been long reported [36]. Thereafter, Tale et al. proposed the basal activity of
SK as the most important factor for the accumulation of de novo formed Cer in breast cancer
cells [37]. We further demonstrated that, in proliferating MDCK cells, the high level of SK
expression and S1P endogenous level negatively control the de novo synthesis pathway by pre-
venting Cer accumulation, which leads to the preponderance of S1P over Cer necessary for
maintaining the proliferative state of cells [9]. We also demonstrated that the decrease in the
endogenous levels of S1P evoked by SK inhibition triggers the de novo pathway with accumula-
tion of Cer, thus causing cell death [9]. Based on this evidence, we hypothesized that, by con-
trolling the de novo pathway of sphingolipid metabolism, basal SK/S1P could play a central
role in determining cellular fate. Previously, by studying the sphingolipid content in the kidney
of neonatal and adult rats, which represent non-differentiated/proliferating cells and fully dif-
ferentiated/non-proliferating cells respectively, we found highest concentration of S1P in the
neonatal period and decreased levels in the adult life, and Cer and SM increased contents in
the adult [8,38]. To evaluate the physiological role of sphingolipid, in the present study, we
emulated kidney development and maturation by using MDCK cells in different physiological
stages: non-differentiated proliferating, polarized and differentiated cells. Consistent with the
SK and S1P temporal gradient reported in developing and adult kidney, here we showed high-
est levels of SK and S1P in proliferating cells, decreasing levels in polarized cells, and lowest
levels in differentiated cells (Fig 1). We also found that proliferating and polarized MDCK cells
were highly sensitive to the endogenous levels of S1P and that, as cells mature, they become
more resistant to endogenous S1P, suggesting that the survival of differentiated cells is inde-
pendent of the endogenous levels of S1P (Fig 1). However, even in differentiated cells, the
endogenous levels of S1P control the de novo synthesis pathway, as reflected by the increase in
the radioactivity associated with the various sphingolipid metabolites when endogenous S1P
synthesis was inhibited (Fig 7). Interestingly, the results using S1P-depleted medium showed
that S1P modulates the sphingolipid metabolism by an intracellular mechanism and that S1P
receptors are not involved (S2 Fig). Then, we were interested in elucidating the role, if any, of
the regulation of sphingolipid metabolism exerted by S1P levels in cells in process of differenti-
ation. Under basal conditions, the distribution of the radioactivity among the various metabo-
lites in cells in process of differentiation and already differentiated cells was almost equal.
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However, the triggering of the de novo pathway evoked by SK inhibition resulted in higher
accumulation of Cer in non-differentiated cells, while differentiated cells directed the meta-
bolic pathway to the formation of SM and GluCer. This result is consistent with our previous
observation that the activity and expression of both SM and GluCer synthases are increased in
differentiated MDCK cells. This increased formation of sphingolipid metabolites resulted in
the draining of de novo formed Cer, thus buffering its intracellular accumulation, which finally
prevents its deleterious effects. The inhibition of SK in cells in progress to differentiation
impaired the acquisition of the differentiated phenotype of MDCK cells and affected the adhe-
sion to neighboring cells (Figs 2 and 3). It is known that the assembly of E-cad-based AJs is
obligatory for the establishment of cell-cell adhesion [39]. Two major steps have to occur for
the establishment of mature cell-cell adhesion: the formation of the E-cad/ β-cat/α-cat complex
and its trafficking to the plasma membrane. The mechanism of the cadherin/catenins complex
assembly and the targeting of E-cad to the basolateral membrane domain have been intensively
studied recently. It has been suggested that β-cat binds E-cad co-translationally, but that α-cat
binds after the complex has been transported to the plasma membrane [40,41]. However,
more recent evidence supports the idea that β-cat and α-cat form a complex in the cytosol and,
thereafter, the complex must be transported to the plasma membrane, where linkage to the
actin cytoskeleton occurs [42,43]. Our experiments indicate that inhibition of SK does not
seem to interfere with the assembly of the E-cad/β-cat/α-cat complex but that the complex
remains in the TGN (Fig 4), secondary to a disbalance in the sphingolipid de novo synthesis,
which causes Cer accumulation. This idea is supported by two observations. First, the AJ com-
plex dissipated from the Golgi when de novo Cer synthesis was inhibited and, concomitantly,
the cellular phenotype was rescued (Fig 5). We hypothesized that cells in progress to differenti-
ation are unable to drain sufficiently the excess of de novo formed Cer which accumulates in
the TGN. Thereafter, Cer accumulation probably generates a highly hydrophobic lipid
domain, thus sequestering the AJ complex, probably blocking its vesicular traffic to the plasma
membrane. Since the half-life of E-cad is rather short [44,45], retention of E-cad in the TGN
would result in reduced cell surface expression of E-cad and consequently in the impairment
of cell-cell adhesion. In contrast to cells in differentiation, differentiated cells were able to pre-
vent E-cad/catenins retention in the TGN, thus preserving cell-cell adhesion (Fig 5). This was
probably because they are more efficient to drain the de novo formed Cer.
It is accepted that E-cad is able to form a complex with catenins linked to the actin cytoskel-
eton, allowing the formation of the actin cortex, which is necessary to maintain the typical epi-
thelial cell shape as seen in differentiated MDCK cells (Fig 2). The inhibition of SK induced a
remodeling of the actin cytoskeleton all over the cell area. These effects caused changes in the
cell morphology and cellular phenotype commonly observed in the EMT.
It is accepted that the loss of cell adhesion is a key step of the EMT. Mesenchymal transition
in kidney collecting duct cells associated with disruption of E-cad/catenin-based cell adhesion
has been previously reported [46]. Ivanova et al. demonstrated the ability of renal collecting
duct cells to undergo EMT by disruption of the plasma membrane E-cad/catenin complex
when stimulated by TGFβ [46]. Cadherin-based adhesion is not a static condition but rather a
dynamic equilibrium between the cadherin complex at AJs and those in intracellular vesicles
and compartments [47,48]. The pool of intracellular vesicles is composed of vesicles that come
from endocytosis or from the TGN sorting to the plasma membrane [49]. Adhesion and endo-
cytosis are closely opposed processes and disruption of the E-cad-based cell adhesion is com-
monly associated with an abuse of endocytosis over adhesion [47]. However, it is also
considered that the proper sorting of E-cad and the efficient formation of vesicles are crucial
steps for maintaining cadherin tracking and its cellular function. Delivery and turnover of E-
cad at the plasma membrane provide a ready-made mechanism for cells to modulate cell
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adhesion depending on the adhesion requirements. Le et al. demonstrated that, in confluent
polarized MDCK cells, a small amount of surface E-cad recycles to and from the plasma mem-
brane, even in the absence of exogenous experimental manipulation [47,48]. Our results
showed that the disbalance of the de novo formed Cer induced by SK inhibition affects the
steps of the formation of the E-cad/catenin-containing vesicles directed to adhesion. Consider-
ing that a portion of the internalized cadherin can also enter late endosomes to be degraded
and that the engagement of the vesicle trafficking machinery is deficient, cells in the process of
differentiation may not accomplish the increased adhesion and consequently undergo EMT
instead of differentiating.
The EMT is commonly accompanied by the nuclear translocation of the transcription fac-
tor Snail, which promotes EMT during development [50]. The Snail superfamily of transcrip-
tion factors represses the transcription of E-cad, thus emerging as key regulators in the EMT
process [51]. Our experiments showed that nuclear translocation of Snail I and II was second-
ary to Cer accumulation since, when de novo Cer synthesis was inhibited, Snail nuclear accu-
mulation dissipated (Fig 6). This suggests that the signal for Snail translocation occurs at the
time when plasma membrane E-cad diminishes and that when E-cad-based cell adhesion is re-
established, Snail I and II dissipate from the nucleus. This result is consistent with the previous
observation of Ivana et al., who described that disruption of E-cad/catenin-based adhesion
together with SNAIL nuclear translocation are both early events in the EMT [46]. Although
controversial with the commonly accepted concept that SNAIL nuclear translocation precedes
E-cad/catenin-based cell adhesion disruption, our results showed that both phenomena seem
to occur instantly and both stem from the accumulation of de novo Cer.
Interestingly, by performing SK1 or SK2 knockdown experiments we demonstrated that
SK1, but not SK2, is the isoform involved in the regulation of sphingolipid metabolism and the
consequent acquisition of a differentiated phenotype, thus reinforcing the concept that SK1
and SK2 can have different physiological implications [52,53].
In conclusion, the results of this work show additional evidence about the role of sphingoli-
pid metabolism in cellular fate, emphasizing the role of SK/S1P pathway in the regulation of
Cer de novo synthesis. We suggest that the expression and activity of SK act as a control system,
allowing the cells to synchronize the various branches of sphingolipid metabolism to ade-
quately respond to the cellular demand.
Further important evidence that emerges from these results is the high resistance of differ-
entiated cells to the low levels of S1P, in contrast with proliferating cells or cells that suffered
EMT. Taking into consideration that S1P is considered an oncometabolite because of its high
expression in many cancer cells, our evidence about the different susceptibility of cells to SK
inhibition could be of high importance for the therapy of cancer, since at concentrations of SK
inhibitors that are lethal for cancer cells, normal cells probably survive.
Supporting information
S1 Fig. Effect of S1P-depleted FBS on cell morphology. The acquisition of the differentiated
phenotype was analyzed by β-cat and F-actin distribution in cells cultured with S1P-depleted
or non-depleted FBS. Cells were subjected to hypertonicity and treated with SK inhibitors
(H48+t-DHS48 or H48+SKI II48) and 10 μM S1P (H48+t-DHS/S1P48 or H48+SKI II/S1P48).
(TIF)
S2 Fig. Effect of S1P-depleted FBS on sphingolipid metabolism. Radiolabeled precursor
incorporation in cells cultured with S1P-depleted vs non-depleted FBS. MDCK cells were
incubated with S1P-depleted or non-depleted FBS and labeled with [14C] palmitic acid for 4 h
before trypsinization. Sphingolipids were resolved as described previously. Graphs show the
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incorporation of [14C] palmitic acid to Cer, GluCer and SM in cells subjected to hypertonicity
(H48) in the presence of t-DHS, SKI II W146 or JTE-013 (H48+t-DHS48, H48+t-SKI II48,
H48+10μM W146 or H48+10μM JTE-013) and with addition of exogenous 10 μM S1P (H48+t-
DHS/S1P48 or H48+SKI II /S1P48). Data are given as mean ± SD with n = 3, �p< 0.05 vs S1P
non-depleted control (non-depleted-H48) or ˆp< 0.05 vs S1P-depleted control (S1P-depleted-
H48).
(TIF)
S3 Fig. Uncropped Western blots. The figure shows the original uncropped and unadjusted
blots corresponding to (A) Fig 1, SK1 and actin and (B) Fig 3, E-cad. Bands in the E-cad blot
correspond to E-cadherin (120/80 kDa) and E-cadherin precursor (135 kDa), according to
manufacturer’s datasheet. In Fig 1, a mature E-cadherin band (~120 kDa) has been shown.
The 35 kDa band could correspond to cleavage E-cadherin (35 kDa).
(TIF)
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